Medsafe

The case of ADHD specialist GP Tony Hanne excited much comment last month, not least from pharmacy owner Ian McMichael who is concerned about the impact of bad prescribing on pharmacists and potential liability, writes Jonathan Chilton-Towle

An 89-year-old woman who was prescribed Paxlovid despite having a contraindication for the COVID-19 antiviral collapsed four days later and was taken to hospital

Medsafe has issued a warning that myocarditis and pericarditis may be possible side effects of the new Novavax COVID-19 vaccine, Nuvaxovid 

Medsafe is urging feedback from pharmacists about safety warnings on some eye drops 

Medsafe will soon require all medicines containing opioids to display a warning that they are addictive and can cause overdoses

A Medsafe investigation has confirmed no contaminated Lucas’ Papaw Ointment made it into New Zealand, despite a company importing it from Australia outside normal distribution channels.

Pharmacy audit compliance has continued to fall, with just over 40 per cent of pharmacies achieving full audit compliance in the last reporting quarter. This is down from 44 per cent full compliance in the previous quarter and 49 per cent full compliance a year ago

Pharmacy audit compliance has continued to fall, with just over 40 per cent of pharmacies achieving full audit compliance in the last reporting quarter. This is down from 44 per cent full compliance in the previous quarter and 49 per cent full compliance a year ago.

Medsafe this week approved the first of two antiviral COVID-19 treatments suitable for community use, but the earliest they will be available is April 

Shingles tops Medsafe’s list of‘adverse effects of special interest’ – but can the jab actually cause shingles? Anna Lee investigates